Table 1.
Treatment scenario and services provided for the outpatient setting (low and intermediate follow-up).
| Service | Initial consultation (all patients) | Outpatient management | |
|---|---|---|---|
| Low follow-up | Intermediate follow-up | ||
| Duration | — | 8 weeks | 8 weeks∗ |
| Consultation | 1x | Every 7-10 days (6x) | Weekly (8x) |
| Blood pressure measurement | 1x | Every 7-10 days (6x) | Weekly (8x) |
| Blood analyses (ALAT/GPT, ASAT/GOT, LDH, haptoglobin, creatinine) | 1x | — | Weekly (8x) |
| Fetal ultrasound with Doppler/CTG | 1x | Every 7-10 days (6x) | Weekly (8x) |
| Proteinuria (quantitative) | 1x | — | — |
| Proteinuria (fast strip) | — | Every 7-10 days (6x) | Weekly (8x) |
| sFlt-1/PlGF ratio | 1x | — | — |
| Costs per week (€) | 531 | 200 | 547 |
∗Based on the assumption that a proportion of women would be hospitalized after 4 weeks. ALAT/GPT: alanine aminotransferase; ASAT/GOT: aspartate aminotransferase; CTG: cardiotocography; LDH: lactate dehydrogenase; PlGF: placental growth factor; sFlt-1: soluble fms-like tyrosine kinase-1.